Last Updated: June 18, 2026

Suppliers and packagers for MIDOZALAM HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


MIDOZALAM HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Onesource Specialty MIDOZALAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 090316 ANDA SOMERSET THERAPEUTICS, LLC 70069-818-10 10 VIAL in 1 CARTON (70069-818-10) / 10 mL in 1 VIAL 2023-12-05
Onesource Specialty MIDOZALAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 090316 ANDA Steriscience Specialties Private Limited 82449-207-02 10 VIAL in 1 CARTON (82449-207-02) / 10 mL in 1 VIAL 2023-07-31
Onesource Specialty MIDOZALAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 090316 ANDA Steriscience Specialties Private Limited 82449-208-02 10 VIAL in 1 CARTON (82449-208-02) / 5 mL in 1 VIAL 2023-07-31
Onesource Specialty MIDOZALAM HYDROCHLORIDE midazolam hydrochloride INJECTABLE;INJECTION 090316 ANDA Steriscience Specialties Private Limited 82449-209-02 10 VIAL in 1 CARTON (82449-209-02) / 10 mL in 1 VIAL 2023-07-31
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for MIDOZALAM HYDROCHLORIDE

Last updated: April 27, 2026

Who Supplies Midozalam Hydrochloride (Pharmaceutical-Grade Midazolam HCl)?

Midozalam hydrochloride is the trade/variant naming used for midazolam hydrochloride, a controlled, benzodiazepine-class API used in anesthesia, procedural sedation, and other indications. Supplier availability is mostly captured through API distributors and specialty chemical suppliers rather than open, publicly listed “drug manufacturers” lists.

Because you asked only for “suppliers,” the actionable way to map this procurement is by identifying typical supplier categories and the supply channels that carry midazolam hydrochloride. In practice, procurement teams source midazolam HCl via:

  • Licensed API distributors (inventory holders and channel partners)
  • Specialty pharmaceutical ingredient manufacturers (API production or toll manufacturing)
  • DEA/competent authority compliant distributors for controlled substances (where applicable)

What Supplier Types Typically Carry Midazolam Hydrochloride API?

1) Authorized API Distributors

These firms stock and distribute midazolam hydrochloride API to licensed customers (manufacturers, labs, wholesalers). They typically provide:

  • COA, CoC, spec sheets
  • Regulatory documentation support (traceability, controlled substance handling documentation where required)
  • batch-lot traceability

Procurement tends to be fastest when distributors can supply small to medium batches with frequent reorders.

2) API Manufacturers and Specialty Chemical Producers

Midazolam HCl is typically produced in dedicated chemical manufacturing facilities with validated controls for:

  • impurity profiles
  • residual solvents
  • polymorph and salt form control
  • batch consistency

These suppliers are more suitable for long-term supply programs and higher volume needs.

3) Controlled Substance Logistics/Distribution Channels

Midazolam is a regulated benzodiazepine in many jurisdictions, and suppliers that operate in those markets usually route procurement through:

  • licensed warehouses
  • controlled substance transport
  • customer qualification checks

This category affects lead time and documentation requirements more than the chemical itself.

Procurement Benchmarks for Midazolam Hydrochloride API

While supplier names vary by region and customer qualification status, buyers generally evaluate suppliers against the same technical and compliance criteria.

API Specifications Buyers Commonly Require

  • Assay: midazolam hydrochloride within pharmacopeial target range
  • Impurity profile: specified thresholds for related substances
  • Residual solvents: aligned to ICH Q3C guidance
  • Water content / loss on drying or equivalent parameter
  • Microbial limits (if required by the use case)
  • Particle size (if relevant to formulation)

Regulatory and Compliance Deliverables

  • COA per lot
  • DMF status (if available) or equivalent regulatory dossier support
  • GMP certificate for manufacturing site (for pharmaceutical-grade API)
  • Controlled substance handling documentation for shipments where required

Supplier Shortlisting Framework (What to Match, Fast)

Match supplier capability to the intended use

  • Clinical or commercial API: prioritize GMP API manufacturers or distributors with GMP supply chain documentation.
  • R&D reference material / internal assay use: prioritize suppliers that can provide controlled quality documentation for small lots.

Match the supply model

  • Stocked supply: distributors typically offer faster lead times.
  • Manufactured-to-order: manufacturers can support larger commitments and custom specs but require longer qualification timelines.

Match the documentation package

  • Buyers should align on: COA format, impurity reporting basis, residual solvent reporting, and whether supplier can support regulatory filings (e.g., through DMF or a comparable dossier).

Where to Find Midazolam HCl Suppliers in the Real World (Procurement Channels)

Commercial API marketplaces

  • Large pharmaceutical ingredient directories and procurement platforms list midazolam hydrochloride across multiple countries, typically with filtering by grade (pharmaceutical), GMP, and shipping region.

Licensed distributor networks

  • Distributors that serve anesthesia, critical care, and generics supply chains often carry benzodiazepine APIs and can confirm controlled substance logistics.

Direct manufacturer sourcing

  • API manufacturers often do not list openly as “suppliers” in generic chemical search results. They sell through qualified distributors or by direct qualification.

Key Takeaways

  • “Midozalam hydrochloride” refers to midazolam hydrochloride (API).
  • Supplier sourcing is typically handled through authorized API distributors, GMP API manufacturers, and controlled-substance compliant logistics channels.
  • Procurement success depends on matching the supplier’s GMP status, lot documentation (COA/impurity/residual solvents), and controlled substance handling capability.
  • Midazolam HCl supply is often faster from licensed distributors with stocked inventory; long-term volume is typically sourced from API manufacturers.

FAQs

1) Is “Midozalam hydrochloride” the same as midazolam hydrochloride?

Yes. The underlying substance is midazolam hydrochloride under a variant/trade naming convention.

2) Who can legally supply midazolam hydrochloride API?

Suppliers must be licensed/authorized for controlled substances in the relevant jurisdictions and qualified to ship to authorized customer types.

3) What documentation should procurement require for midazolam HCl API?

At minimum: COA per lot, GMP certificate for the manufacturing site, and impurity/residual solvent reporting consistent with the buyer’s spec.

4) Are distributors or manufacturers better for R&D vs commercial supply?

Distributors are often better for faster R&D procurement; manufacturers are typically better for commercial scale and sustained supply under qualification.

5) What factors most affect lead time for midazolam HCl?

Controlled substance logistics, customer qualification, inventory availability (stock vs made-to-order), and dossier readiness (COA/spec consistency).

Cited Sources (APA)
[1] U.S. Drug Enforcement Administration (DEA). Controlled Substances. https://www.deadiversion.usdoj.gov/
[2] ICH. ICH Q3C: Impurities: Residual Solvents. https://www.ich.org/
[3] European Pharmacopoeia. Monographs: Benzodiazepines (including midazolam hydrochloride). https://www.edqm.eu/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.